Zunveyl is supplied as 5mg, 10mg, and 15mg delayed-release tablets, which can be taken with or without food. Zunveyl ® (benzgalantamine) is now available for the treatment of mild to moderate dementia ...
"What should I eat?" is perhaps the most common question patients with inflammatory bowel disease ask their doctors.
Please provide your email address to receive an email when new articles are posted on . High FeNO levels indicate exacerbation and lung function risks. Most patients with high FeNO levels also had ...
More patients in FMD group met primary outcome of clinical response and prespecified secondary outcome of clinical remission.
The National Psoriasis Foundation issued a new position statement that clarifies the definition of psoriasis disease severity ...
A form of very low-calorie fasting-mimicking diet may help alleviate symptoms of mild-to-moderate Crohn's disease.
SAINT-PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world evidence of the effectiveness of a treat-to-target (T2T) ...
A mindfulness-based cognitive therapy self-help (MBCT-SH) intervention in which patients were supported by a trained practitioner led to better clinical outcomes at lower cost than ...